{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T22:24:53Z","timestamp":1779315893295,"version":"3.51.4"},"reference-count":61,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["brachyjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.brachy.2019.12.004","type":"journal-article","created":{"date-parts":[[2020,1,18]],"date-time":"2020-01-18T00:10:24Z","timestamp":1579306224000},"page":"255-263","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Can intermediate-energy sources lead to elevated bone doses for prostate and head & neck high-dose-rate brachytherapy?"],"prefix":"10.1016","volume":"19","author":[{"given":"Gabriel","family":"Famulari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanne","family":"Alfieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Duclos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T\u00e9","family":"Vuong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shirin A.","family":"Enger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2019.12.004_bib1","doi-asserted-by":"crossref","first-page":"6208","DOI":"10.1118\/1.4747264","article-title":"Report of the Task Group 186 on model-based dose calculation methods in brachytherapy beyond the TG-43 formalism: current status and recommendations for clinical implementation","volume":"39","author":"Beaulieu","year":"2012","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2019.12.004_bib2","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1118\/1.595838","article-title":"Selenium-75: a potential source for use in high-activity brachytherapy irradiators","volume":"13","author":"Weeks","year":"1986","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2019.12.004_bib3","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1118\/1.596813","article-title":"Ytterbium-169: calculated physical properties of a new radiation source for brachytherapy","volume":"19","author":"Mason","year":"1992","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2019.12.004_bib4","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1259\/0007-1285-65-771-252","article-title":"The potential of ytterbium 169 in brachytherapy: a brief physical and radiobiological assessment","volume":"65","author":"Loft","year":"1992","journal-title":"Br J Radiol"},{"key":"10.1016\/j.brachy.2019.12.004_bib5","first-page":"18","article-title":"Radioactivity measurements of ytterbium169 brachytherapy sources","volume":"21","author":"MacPherson","year":"1998","journal-title":"Australas Phys Eng Sci Med"},{"key":"10.1016\/j.brachy.2019.12.004_bib6","doi-asserted-by":"crossref","first-page":"3832","DOI":"10.1118\/1.2126821","article-title":"A dosimetric comparison of 169Yb versus 192Ir for HDR prostate brachytherapy","volume":"32","author":"Lymperopoulou","year":"2005","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2019.12.004_bib7","doi-asserted-by":"crossref","first-page":"3614","DOI":"10.1118\/1.2760306","article-title":"On the use of high dose rate 192Ir and 169Yb sources with the MammoSite radiation therapy system","volume":"34","author":"Papagiannis","year":"2007","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2019.12.004_bib8","doi-asserted-by":"crossref","first-page":"199","DOI":"10.5114\/jcb.2011.26471","article-title":"Comparison of 60Co and 192Ir sources in HDR brachytherapy","volume":"3","author":"Strohmaier","year":"2011","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.brachy.2019.12.004_bib9","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1088\/0031-9155\/58\/4\/957","article-title":"Gadolinium-153 as a brachytherapy source","volume":"58","author":"Enger","year":"2013","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.brachy.2019.12.004_bib10","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.apradiso.2017.09.028","article-title":"Practical aspects of 153Gd as a radioactive source for use in brachytherapy","volume":"130","author":"Famulari","year":"2017","journal-title":"Appl Radiat Isot"},{"key":"10.1016\/j.brachy.2019.12.004_bib11","doi-asserted-by":"crossref","first-page":"4426","DOI":"10.1002\/mp.12335","article-title":"Comparison of 192Ir, 169Yb, and 60Co high-dose rate brachytherapy sources for skin cancer treatment","volume":"44","author":"Safigholi","year":"2017","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2019.12.004_bib12","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1002\/mp.13563","article-title":"Efficient 169Yb high-dose-rate brachytherapy source production using re-activation","volume":"46","author":"Flynn","year":"2019","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2019.12.004_bib13","doi-asserted-by":"crossref","first-page":"051703","DOI":"10.1118\/1.4870441","article-title":"Interstitial rotating shield brachytherapy for prostate cancer","volume":"41","author":"Adams","year":"2014","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2019.12.004_bib14","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.ijrobp.2017.06.008","article-title":"Multisource rotating shield brachytherapy apparatus for prostate cancer","volume":"99","author":"Dadkhah","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2019.12.004_bib15","doi-asserted-by":"crossref","first-page":"6538","DOI":"10.1002\/mp.12598","article-title":"Direction modulated brachytherapy (DMBT) for treatment of cervical cancer: a planning study with 192Ir, 60Co, and 169Yb HDR sources","volume":"44","author":"Safigholi","year":"2017","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2019.12.004_bib16","first-page":"193","article-title":"Technical note: Monte Carlo calculations for the AAPM TG-43 brachytherapy dosimetry parameters for the titanium-encapsulated Yb-169 source","volume":"18","author":"Reynoso","year":"2017","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2019.12.004_bib17","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1118\/1.597458","article-title":"Dosimetry of interstitial brachytherapy sources: recommendations of the AAPM radiation therapy committee Task Group 43","volume":"22","author":"Nath","year":"1995","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2019.12.004_bib18","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1118\/1.1646040","article-title":"Update of AAPM Task Group No. 43 Report: a revised AAPM protocol for brachytherapy dose calculations","volume":"31","author":"Rivard","year":"2004","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2019.12.004_bib19","doi-asserted-by":"crossref","first-page":"73","DOI":"10.5114\/jcb.2018.74327","article-title":"A comparative assessment of inhomogeneity and finite patient dimension effects in 60Co and 192Ir high-dose-rate brachytherapy","volume":"10","author":"Fotina","year":"2018","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.brachy.2019.12.004_bib20","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1088\/0031-9155\/49\/12\/014","article-title":"The effect of patient inhomogeneities in oesophageal 192Ir HDR brachytherapy: a Monte Carlo and analytical dosimetry study","volume":"49","author":"Anagnostopoulos","year":"2004","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.brachy.2019.12.004_bib21","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/j.ijrobp.2004.12.065","article-title":"The effect of finite patient dimensions and tissue inhomogeneities on dosimetry planning of 192Ir HDR breast brachytherapy: a Monte Carlo dose verification study","volume":"61","author":"Pantelis","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2019.12.004_bib22","doi-asserted-by":"crossref","first-page":"394","DOI":"10.4103\/0973-1482.103519","article-title":"The effect of rib and lung heterogeneities on the computed dose to lung in Ir-192 high-dose-rate breast brachytherapy: Monte Carlo versus a treatment planning system","volume":"8","author":"Yazdi","year":"2012","journal-title":"J Cancer Res Ther"},{"key":"10.1016\/j.brachy.2019.12.004_bib23","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1118\/1.2962342","article-title":"MO-D-AUD B01: an analytical approach to account for shielding, anatomical heterogeneities and patient dimensions for 192Ir high dose rate brachytherapy applications","volume":"35","author":"Poon","year":"2008","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2019.12.004_bib24","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.brachy.2015.08.003","article-title":"Validation of the Oncentra Brachy Advanced Collapsed cone Engine for a commercial 192Ir source using heterogeneous geometries","volume":"14","author":"Ma","year":"2015","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2019.12.004_bib25","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/rpd\/ncr337","article-title":"Monte Carlo estimation of dose difference in lung from 192Ir brachytherapy due to tissue inhomogeneity","volume":"147","author":"Gialousis","year":"2011","journal-title":"Radiat Prot Dosimetry"},{"key":"10.1016\/j.brachy.2019.12.004_bib26","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1120\/jacmp.v16i5.5407","article-title":"Optimum radiation source for radiation therapy of skin cancer","volume":"16","author":"Safigholi","year":"2015","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.brachy.2019.12.004_bib27","doi-asserted-by":"crossref","first-page":"4583","DOI":"10.1118\/1.2392408","article-title":"A dosimetric comparison of 169Yb and 192Ir for HDR brachytherapy of the breast, accounting for the effect of finite patient dimensions and tissue inhomogeneities","volume":"33","author":"Lymperopoulou","year":"2006","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2019.12.004_bib28","doi-asserted-by":"crossref","first-page":"4038","DOI":"10.1118\/1.3458720","article-title":"Effects of breast-air and breast-lung interfaces on the dose rate at the planning target volume of a MammoSite catheter for Yb-169 and Ir-192 HDR sources","volume":"37","author":"Cazeca","year":"2010","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2019.12.004_bib29","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.radonc.2012.01.007","article-title":"Randomised trial of external beam radiotherapy alone or combined with high-dose-rate brachytherapy boost for localised prostate cancer","volume":"103","author":"Hoskin","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2019.12.004_bib30","author":"Gay"},{"key":"10.1016\/j.brachy.2019.12.004_bib31","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.radonc.2009.01.005","article-title":"GEC-ESTRO recommendations for brachytherapy for head and neck squamous cell carcinomas","volume":"91","author":"Mazeron","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2019.12.004_bib32","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1118\/1.598418","article-title":"Monte Carlo-aided dosimetry of a new high dose-rate brachytherapy source","volume":"25","author":"Daskalov","year":"1998","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2019.12.004_bib33","series-title":"Theoretical and Practical Specific Activities and Other Properties of Common Radionuclides","author":"Reynolds","year":"1973"},{"key":"10.1016\/j.brachy.2019.12.004_bib34","doi-asserted-by":"crossref","first-page":"S118","DOI":"10.1016\/S0167-8140(16)31505-5","article-title":"OC-0256: column generation-based Monte Carlo treatment planning for rotating shield brachytherapy","volume":"119","author":"Renaud","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2019.12.004_bib35","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.ijrobp.2009.08.048","article-title":"RTOG-0321 protocol: phase II trial of combined high dose rate brachytherapy and external beam radiotherapy for adenocarcinoma of the prostate","volume":"78","author":"Hsu","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2019.12.004_bib36","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.radonc.2016.10.008","article-title":"GEC-ESTRO ACROP recommendations for head & neck brachytherapy in squamous cell carcinomas: 1st update - improvement by cross sectional imaging based treatment planning and stepping source technology","volume":"122","author":"Kov\u00e1cs","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2019.12.004_bib37","series-title":"Photon, Electron, Proton and Neutron Interaction Data for Body Tissues: Report 46","year":"1992"},{"key":"10.1016\/j.brachy.2019.12.004_bib38","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.ijrobp.2016.11.025","article-title":"Large-scale retrospective Monte Carlo dosimetric study for permanent implant prostate brachytherapy","volume":"97","author":"Miksys","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2019.12.004_bib39","doi-asserted-by":"crossref","first-page":"175007","DOI":"10.1088\/1361-6560\/aad97a","article-title":"RapidBrachyMCTPS: a Monte Carlo-based treatment planning system for brachytherapy applications","volume":"63","author":"Famulari","year":"2018","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.brachy.2019.12.004_bib40","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0168-9002(03)01368-8","article-title":"Geant4 - a simulation toolkit","volume":"506","author":"Agostinelli","year":"2003","journal-title":"Nucl Instrum Methods Phys Res A"},{"key":"10.1016\/j.brachy.2019.12.004_bib41","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1109\/TNS.2006.869826","article-title":"Geant4 developments and applications","volume":"53","author":"Allison","year":"2006","journal-title":"IEEE Trans Nucl Sci"},{"key":"10.1016\/j.brachy.2019.12.004_bib42","series-title":"Evaluated Nuclear Structure Data File, a Manual for Preparation of Data Sets","author":"Tuli","year":"1987"},{"key":"10.1016\/j.brachy.2019.12.004_bib43","series-title":"EPDL97: The Evaluated Photon Data Library, \u201997 Version. LLNL Report No. UCRL-50400","author":"Cullen","year":"1997"},{"key":"10.1016\/j.brachy.2019.12.004_bib44","series-title":"Table and graphs of electron-interaction cross sections from 10 eV to 100 GeV derived from the LLNL Evaluated Electron Data Library (EEDL). LLNL Report No. UCRL-50400-V-31","author":"Perkins","year":"1997"},{"key":"10.1016\/j.brachy.2019.12.004_bib45","series-title":"Tables and Graphs of Atomic Subshell and Relaxation Data Derived from the LLNL Evaluated Atomic Data Library (EADL), Z\u00a0= 1-100. LLNL Report No. UCRL-50400-V-30","author":"Perkins","year":"1997"},{"key":"10.1016\/j.brachy.2019.12.004_bib46","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1118\/1.596069","article-title":"Monte Carlo evaluation of kerma at a point for photon transport problems","volume":"14","author":"Williamson","year":"1987","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2019.12.004_bib47","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.radonc.2018.01.007","article-title":"The influence of tissue composition uncertainty on dose distributions in brachytherapy","volume":"126","author":"Mann-Krzisnik","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2019.12.004_bib48","first-page":"e1","article-title":"RECORDS: improved reporting of Monte Carlo RaDiation transport studies: report of the AAPM Research committee Task Group 268","volume":"45","author":"Sechopoulos","year":"2017","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2019.12.004_bib49","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.radonc.2016.01.022","article-title":"On the impact of improved dosimetric accuracy on head and neck high dose rate brachytherapy","volume":"120","author":"Peppa","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2019.12.004_bib50","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1118\/1.3533720","article-title":"A dosimetric uncertainty analysis for photon-emitting brachytherapy sources: report of AAPM Task Group No. 138 and GEC-ESTRO","volume":"38","author":"DeWerd","year":"2011","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2019.12.004_bib51","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1088\/0031-9155\/57\/8\/2117","article-title":"On the uncertainties of photon mass-energy absorption coefficients and their ratios for radiation dosimetry","volume":"57","author":"Andreo","year":"2012","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.brachy.2019.12.004_bib52","series-title":"Khan\u2019s the Physics of Radiation Therapy","author":"Khan","year":"2014"},{"key":"10.1016\/j.brachy.2019.12.004_bib53","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1088\/0031-9155\/60\/11\/4565","article-title":"Dose specification for 192Ir high dose rate brachytherapy in terms of dose-to-water-in-medium and dose-to-medium-in-medium","volume":"60","author":"Fonseca","year":"2015","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.brachy.2019.12.004_bib54","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.1002\/cncr.25994","article-title":"Three-dimensional external beam radiotherapy for prostate cancer increases the risk of hip fracture","volume":"117","author":"Elliott","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.brachy.2019.12.004_bib55","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.ijrobp.2008.08.002","article-title":"RTOG GU Radiation oncology specialists reach consensus on pelvic lymph node volumes for high-risk prostate cancer","volume":"74","author":"Lawton","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2019.12.004_bib56","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.ijrobp.2013.11.241","article-title":"Dosimetric considerations to determine the optimal technique for localized prostate cancer among external photon, proton, or carbon-ion therapy and high-dose-rate or low-dose-rate brachytherapy","volume":"88","author":"Georg","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2019.12.004_bib57","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1590\/S0100-39842012000500007","article-title":"Comparative dosimetry of prostate brachytherapy with I-125 and Pd-103 seeds vis SISCODES\/MCNP","volume":"45","author":"Trindade","year":"2012","journal-title":"Radiol Bras"},{"key":"10.1016\/j.brachy.2019.12.004_bib58","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0167-8140(97)00092-3","article-title":"Analysis of risk factors for mandibular bone radionecrosis after exclusive low dose-rate brachytherapy for oral cancer","volume":"44","author":"Lozza","year":"1997","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2019.12.004_bib59","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1053\/ctrv.2002.0254","article-title":"Radiotherapy-induced mandibular bone complications","volume":"28","author":"Jereczek-Fossa","year":"2002","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.brachy.2019.12.004_bib60","first-page":"1","article-title":"The 2007 recommendations of the international commission on radiological protection. ICRP publication 103","volume":"37","year":"2007","journal-title":"Ann ICRP"},{"key":"10.1016\/j.brachy.2019.12.004_bib61","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ijrobp.2017.09.040","article-title":"Microdosimetric evaluation of current and alternative brachytherapy sources - a Geant4-DNA simulation study","volume":"100","author":"Famulari","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472119306531?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472119306531?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:14:43Z","timestamp":1761531283000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472119306531"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":61,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S1538472119306531"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2019.12.004","relation":{},"ISSN":["1538-4721"],"issn-type":[{"value":"1538-4721","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Can intermediate-energy sources lead to elevated bone doses for prostate and head & neck high-dose-rate brachytherapy?","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2019.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}